"only for private pharma/bio/tech firms to add a thin layer of additional research (or design) on top"

Citation needed.

Go to market cost billions and takes a decade. Doesn't sound like a thin layer. I'm not disputing fundamental research in academia is an essential fuel to keep innovation engines running. But the contributions of biotech is not "thin".